Lev D - Search Results

1

AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas.

May CD, Garnett J, Ma X, Landers SM, Ingram DR, Demicco EG, Al Sannaa GA, Vu T, Han L, Zhang Y, Kivlin CM, Bolshakov S, Kalam AA, Liu J, Zhou F, Broccoli D, Wang WL, Lazar AJ, Pollock RE, Lev D, Torres KE. May CD, et al. Among authors: lev d. BMC Cancer. 2015 Nov 14;15:901. doi: 10.1186/s12885-015-1916-3. BMC Cancer. 2015. PMID: 26573603 Free PMC article.

2

Inhibition of platelet-derived growth factor-mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor STI571.

McGary EC, Weber K, Mills L, Doucet M, Lewis V, Lev DC, Fidler IJ, Bar-Eli M. McGary EC, et al. Clin Cancer Res. 2002 Nov;8(11):3584-91. Clin Cancer Res. 2002. PMID: 12429650

3

Dual blockade of EGFR and ERK1/2 phosphorylation potentiates growth inhibition of breast cancer cells.

Lev DC, Kim LS, Melnikova V, Ruiz M, Ananthaswamy HN, Price JE. Lev DC, et al. Br J Cancer. 2004 Aug 16;91(4):795-802. doi: 10.1038/sj.bjc.6602051. Br J Cancer. 2004. PMID: 15280923 Free PMC article.

4

Vascular endothelial growth factor overexpression by soft tissue sarcoma cells: implications for tumor growth, metastasis, and chemoresistance.

Zhang L, Hannay JA, Liu J, Das P, Zhan M, Nguyen T, Hicklin DJ, Yu D, Pollock RE, Lev D. Zhang L, et al. Among authors: lev d. Cancer Res. 2006 Sep 1;66(17):8770-8. doi: 10.1158/0008-5472.CAN-06-1217. Cancer Res. 2006. PMID: 16951193

5

Staging soft tissue sarcoma: evolution and change.

Kotilingam D, Lev DC, Lazar AJ, Pollock RE. Kotilingam D, et al. Among authors: lev dc. CA Cancer J Clin. 2006 Sep-Oct;56(5):282-91; quiz 314-5. doi: 10.3322/canjclin.56.5.282. CA Cancer J Clin. 2006. PMID: 17005597 Free article. Review.

6

Wild-type p53 inhibits nuclear factor-kappaB-induced matrix metalloproteinase-9 promoter activation: implications for soft tissue sarcoma growth and metastasis.

Liu J, Zhan M, Hannay JA, Das P, Bolshakov SV, Kotilingam D, Yu D, Lazar AF, Pollock RE, Lev D. Liu J, et al. Among authors: lev d. Mol Cancer Res. 2006 Nov;4(11):803-10. doi: 10.1158/1541-7786.MCR-06-0201. Epub 2006 Oct 31. Mol Cancer Res. 2006. PMID: 17077165

7

Isolated limb perfusion: a novel delivery system for wild-type p53 and fiber-modified oncolytic adenoviruses to extremity sarcoma.

Hannay J, Davis JJ, Yu D, Liu J, Fang B, Pollock RE, Lev D. Hannay J, et al. Among authors: lev d. Gene Ther. 2007 Apr;14(8):671-81. doi: 10.1038/sj.gt.3302911. Epub 2007 Feb 8. Gene Ther. 2007. PMID: 17287860

8

High prevalence of p53 exon 4 mutations in soft tissue sarcoma.

Das P, Kotilingam D, Korchin B, Liu J, Yu D, Lazar AJ, Pollock RE, Lev D. Das P, et al. Among authors: lev d. Cancer. 2007 Jun 1;109(11):2323-33. doi: 10.1002/cncr.22680. Cancer. 2007. PMID: 17429838 Free article.

9

Optimizing treatment of desmoid tumors.

Lev D, Kotilingam D, Wei C, Ballo MT, Zagars GK, Pisters PW, Lazar AA, Patel SR, Benjamin RS, Pollock RE. Lev D, et al. J Clin Oncol. 2007 May 1;25(13):1785-91. doi: 10.1200/JCO.2006.10.5015. J Clin Oncol. 2007. PMID: 17470870

10

Rad51 overexpression contributes to chemoresistance in human soft tissue sarcoma cells: a role for p53/activator protein 2 transcriptional regulation.

Hannay JA, Liu J, Zhu QS, Bolshakov SV, Li L, Pisters PW, Lazar AJ, Yu D, Pollock RE, Lev D. Hannay JA, et al. Among authors: lev d. Mol Cancer Ther. 2007 May;6(5):1650-60. doi: 10.1158/1535-7163.MCT-06-0636. Mol Cancer Ther. 2007. PMID: 17513613

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

487 results

Search Page